Literature DB >> 7425614

Lack of toxicity of acyclovir to granulocyte progenitor cells in vitro.

R W McGuffin, F M Shiota, J D Meyers.   

Abstract

Granulocyte progenitor cells were grown with acyclovir to study potential marrow toxicity. Concentrations of up to 220 microM had little effect on progenitor cell growth.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7425614      PMCID： PMC284024          DOI： 10.1128/AAC.18.3.471

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine.

Authors:  G B Elion; P A Furman; J A Fyfe; P de Miranda; L Beauchamp; H J Schaeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

Authors:  H J Schaeffer; L Beauchamp; P de Miranda; G B Elion; D J Bauer; P Collins
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

3.  A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts.

Authors:  P E Neiman; W Reeves; G Ray; N Flournoy; K G Lerner; G E Sale; E D Thomas
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

4.  Effect of vidarabine on chronic hepatitis B virus infection.

Authors:  R B Pollard; J L Smith; A Neal; P B Gregory; T C Merigan; W S Robinson
Journal:  JAMA       Date:  1978-04-21       Impact factor: 56.272

5.  Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.

Authors:  C S Crumpacker; L E Schnipper; J A Zaia; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

6.  Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study.

Authors:  R J Whitley; L T Ch'ien; R Dolin; G J Galasso; C A Alford
Journal:  N Engl J Med       Date:  1976-05-27       Impact factor: 91.245

7.  Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

Authors:  J W Singer; P J Fialkow; L Steinmann; V Najfeld; S J Stein; W A Robinson
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

8.  Acyclovir kinetics after intravenous infusion.

Authors:  P de Miranda; R J Whitley; M R Blum; R E Keeney; N Barton; D M Cocchetto; S Good; G P Hemstreet; L E Kirk; D A Page; G B Elion
Journal:  Clin Pharmacol Ther       Date:  1979-12       Impact factor: 6.875

9.  The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.

Authors:  P Collins; D J Bauer
Journal:  J Antimicrob Chemother       Date:  1979-07       Impact factor: 5.790

10.  Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.

Authors:  R J Whitley; S J Soong; R Dolin; G J Galasso; L T Ch'ien; C A Alford
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245
View more
  11 in total

1.  Pharmacologic basis for high-dose oral acyclovir prophylaxis of cytomegalovirus disease in renal allograft recipients.

Authors:  C V Fletcher; J A Englund; C K Edelman; C R Gross; D L Dunn; H H Balfour
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 2.  Clinical pharmacokinetics of acyclovir.

Authors:  O L Laskin
Journal:  Clin Pharmacokinet       Date:  1983 May-Jun       Impact factor: 6.447

3.  Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.

Authors:  T C Meeker; M S Siegel; F M Shiota; J J Crowley; R W McGuffin
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 4.  Acyclovir prophylaxis for herpes simplex virus infection.

Authors:  D Gold; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

5.  In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in human immunodeficiency virus-positive humans.

Authors:  R E Dornsife; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

6.  Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.

Authors:  M A Jacobson; J Gallant; L H Wang; D Coakley; S Weller; D Gary; L Squires; M L Smiley; M R Blum; J Feinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on proliferation of human fibroblasts, peripheral blood mononuclear cells, and granulocyte-monocyte progenitor cells in vitro.

Authors:  A E Wittek; P S Cohen; A M Arvin; S D Smith; C M Koropchak; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

8.  Effect of acyclovir and interferon on human hematopoietic progenitor cells.

Authors:  L M Parker; J M Lipton; N Binder; E L Crawford; M Kudisch; M J Levin
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

9.  Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitro.

Authors:  J P Sommadossi; R Carlisle
Journal:  Antimicrob Agents Chemother       Date:  1987-03       Impact factor: 5.191

10.  Antiviral therapy can reverse the development of immune senescence in elderly mice with latent cytomegalovirus infection.

Authors:  Mark Beswick; Annette Pachnio; Sarah N Lauder; Clive Sweet; Paul A Moss
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.